How to Stimulate and Facilitate Early Stage Antibiotic Discovery
15 June 2020
The discovery of novel antibiotics is essential to combat the rise of antimicrobial resistance. While a number of initiatives are focused on advancing promising leads into the clinic, there is a dearth of effort at stimulating the early stage discovery. We present one pathway that has successfully demonstrated an ability to revitalize fundamental research and reengage researchers.
Further reading: ACS Publications
Author(s): Johannes Zuegg et al
Smart Innovations
OUR UNDERWRITERS
Unrestricted financial support kindly provided by
 |
Antimicrobial Resistance Fighter Coalition |
 |
CDD VAULT Complexity Simplified |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
